{
  "ticker": "REGN",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T14:53:27.739286",
  "count": 81,
  "transactions": [
    {
      "id": 72293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-03-27",
      "transaction_shares": "800",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "32905"
    },
    {
      "id": 113203,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-03-27",
      "transaction_shares": "800",
      "transaction_price": "381.92",
      "transaction_type": "M",
      "shares_after_transaction": "32905"
    },
    {
      "id": 72316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-24",
      "transaction_shares": "1240",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2487"
    },
    {
      "id": 113229,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-24",
      "transaction_shares": "1240",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2487"
    },
    {
      "id": 72269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-03-23",
      "transaction_shares": "2192",
      "transaction_price": "806.47",
      "transaction_type": "S",
      "shares_after_transaction": "18409"
    },
    {
      "id": 72289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-03-23",
      "transaction_shares": "254",
      "transaction_price": "800.59",
      "transaction_type": "S",
      "shares_after_transaction": "200250"
    },
    {
      "id": 72330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-23",
      "transaction_shares": "25000",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "312578"
    },
    {
      "id": 72343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-23",
      "transaction_shares": "10000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "34213"
    },
    {
      "id": 113179,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-03-23",
      "transaction_shares": "2192",
      "transaction_price": "806.47",
      "transaction_type": "S",
      "shares_after_transaction": "18409"
    },
    {
      "id": 113199,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-03-23",
      "transaction_shares": "254",
      "transaction_price": "800.59",
      "transaction_type": "S",
      "shares_after_transaction": "200250"
    },
    {
      "id": 113245,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-23",
      "transaction_shares": "25000",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "312578"
    },
    {
      "id": 113258,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-23",
      "transaction_shares": "10000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "34213"
    },
    {
      "id": 72280,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1006",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 113190,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-03-10",
      "transaction_shares": "1006",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 72281,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-03-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 72344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-01",
      "transaction_shares": "5",
      "transaction_price": "758.2",
      "transaction_type": "S",
      "shares_after_transaction": "19242"
    },
    {
      "id": 113191,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-03-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 113259,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-03-01",
      "transaction_shares": "5",
      "transaction_price": "758.2",
      "transaction_type": "S",
      "shares_after_transaction": "19242"
    },
    {
      "id": 72287,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-22",
      "transaction_shares": "42500",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "366583"
    },
    {
      "id": 113197,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-22",
      "transaction_shares": "42500",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "366583"
    },
    {
      "id": 72257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-12",
      "transaction_shares": "1276",
      "transaction_price": "751.78",
      "transaction_type": "F",
      "shares_after_transaction": "20803"
    },
    {
      "id": 113165,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-12",
      "transaction_shares": "1276",
      "transaction_price": "751.78",
      "transaction_type": "F",
      "shares_after_transaction": "20803"
    },
    {
      "id": 72276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-07",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23079"
    },
    {
      "id": 113186,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-07",
      "transaction_shares": "1000",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23079"
    },
    {
      "id": 72279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-02-06",
      "transaction_shares": "13189",
      "transaction_price": "800.08",
      "transaction_type": "S",
      "shares_after_transaction": "200504"
    },
    {
      "id": 72301,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3613",
      "transaction_price": "482.68",
      "transaction_type": "M",
      "shares_after_transaction": "9860"
    },
    {
      "id": 72329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3071",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4318"
    },
    {
      "id": 113189,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "President and Chief Scientific",
      "transaction_date": "2023-02-06",
      "transaction_shares": "13189",
      "transaction_price": "800.08",
      "transaction_type": "S",
      "shares_after_transaction": "200504"
    },
    {
      "id": 113212,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3613",
      "transaction_price": "482.68",
      "transaction_type": "M",
      "shares_after_transaction": "9860"
    },
    {
      "id": 113244,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-06",
      "transaction_shares": "3071",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4318"
    },
    {
      "id": 72271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-03",
      "transaction_shares": "1021",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2268"
    },
    {
      "id": 72292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-02-03",
      "transaction_shares": "5000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "23581"
    },
    {
      "id": 72314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-02-03",
      "transaction_shares": "739",
      "transaction_price": "764.5",
      "transaction_type": "S",
      "shares_after_transaction": "32105"
    },
    {
      "id": 113181,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-03",
      "transaction_shares": "1021",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2268"
    },
    {
      "id": 113202,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-02-03",
      "transaction_shares": "5000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "23581"
    },
    {
      "id": 113227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-02-03",
      "transaction_shares": "739",
      "transaction_price": "764.5",
      "transaction_type": "S",
      "shares_after_transaction": "32105"
    },
    {
      "id": 72299,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-01",
      "transaction_shares": "2",
      "transaction_price": "752.11",
      "transaction_type": "S",
      "shares_after_transaction": "19345"
    },
    {
      "id": 72327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 113210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-01",
      "transaction_shares": "2",
      "transaction_price": "752.11",
      "transaction_type": "S",
      "shares_after_transaction": "19345"
    },
    {
      "id": 113242,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-02-01",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 72331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "1248"
    },
    {
      "id": 113246,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-27",
      "transaction_shares": "1",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "1248"
    },
    {
      "id": 40261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 72325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 113239,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-06",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 40211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 40212,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40218,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 40222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 40227,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 40228,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 40230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40234,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 40250,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 40251,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 40254,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 40257,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    },
    {
      "id": 72260,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 72261,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 72273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 72282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 72283,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 72285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 72311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 72312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 72318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 72321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    },
    {
      "id": 113168,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "14",
      "transaction_price": "721.48",
      "transaction_type": "S",
      "shares_after_transaction": "19268"
    },
    {
      "id": 113169,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113176,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2037"
    },
    {
      "id": 113183,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6247"
    },
    {
      "id": 113192,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-01-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "23179"
    },
    {
      "id": 113193,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 113195,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113201,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26214"
    },
    {
      "id": 113222,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1247"
    },
    {
      "id": 113224,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Tessier-Lavigne Marc",
      "reporting_owner_cik": "0001437435",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2434"
    },
    {
      "id": 113231,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "40",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "319"
    },
    {
      "id": 113234,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2023-01-03",
      "transaction_shares": "165",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1258"
    }
  ]
}